ZYHCG 5000 iu (ex.Ovidac)

Manufacturer: Cadila, India

Pharmaceutical name: Human Chorionic Gonadotropin

Pack: 1 set (vial 5000 iu + solution)

HCG is a hormone that is naturally generated by the female placenta during a typical pregnancy. The way this medication works closely resembles luteinizing hormone (LH), which is known to induce ovulation. When used alongside other medications, ZYHCG 5000 iu is highly effective in aiding female patients in achieving pregnancy. It can also assist male patients dealing with fertility challenges, often leading to an increase in testosterone production.

 

ZYHCG 5000 iu is frequently prescribed to female patients as part of a treatment plan aimed at: Inducing ovulation in cases of subfertility caused by issues such as impaired follicle maturation or anovulation; Supporting the luteal phase; Preparing follicles for retrieval in controlled ovarian hyperstimulation protocols, particularly during assisted reproductive techniques.

 

ZYHCG 5000 iu is also regularly prescribed to male patients for treating hypogonadotropic hypogonadism. Some individuals with idiopathic dysspermias have shown positive results from this treatment. It is also used for cases of delayed puberty linked to insufficient function of the gonadotropic pituitary glands, as well as cryptorchidism (excluding instances caused by anatomical obstructions).

 

ZYHMG HCG 5000 iu is widely recognized for assisting both male and female patients with infertility. Additionally, this medication may have other applications for treating or preventing various medical conditions not discussed here.

 

For female patients seeking treatment with ZYHCG 5000 iu: Infertile women undergoing assisted reproduction, particularly those needing in vitro fertilization, can frequently experience tubal abnormalities, which may lead to an increased incidence of ectopic pregnancies following treatment. Therefore, early ultrasound confirmation at the beginning of pregnancy is essential to ascertain whether it is intrauterine. Pregnancies resulting from this treatment have a higher risk of multiples. Women with a history of thrombosis, severe obesity, or thrombophilia should avoid this medication due to a heightened risk of thromboembolic events. Furthermore, patients who have received this treatment tend to be more susceptible to pregnancy loss.

 

For male patients: Extended treatment with ZYHCG 5000 iu commonly results in increased androgen production. Consequently, individuals with overt or latent cardiac failure, hypertension, renal dysfunction, migraine, or epilepsy may not be permitted to use this medication or may require a reduced dosage. Caution is advised when prescribing to prepubertal adolescents to minimize risks of premature sexual development or early closure of growth plates, necessitating regular monitoring of their skeletal maturation.

Both male and female patients with the following conditions should not initiate treatment with ZYHCG 2000 iu: hypersensitivity to this medication or any of its active ingredients, and known or suspected androgen-dependent tumors, such as male breast cancer or prostatic carcinoma.

 

Consult your physician regarding when and how to use this medication. It is important to follow all of your physician’s instructions. You can also refer to the medication’s label for additional guidance. If you have further inquiries, consult a doctor, pharmacist, or nurse. ZYHCG 5000 iu should be stored in a refrigerator at a temperature between 2°-8°C. Keep this medication away from direct sunlight and out of reach of pets and children to prevent accidental poisoning.

 

Dosage for female patients: An injection of 5,000-10,000 I.U. should be administered. Dosage for male patients: An injection of 1,000-2,000 I.U. should be given 2 to 3 times a week. It is recommended that each dose of ZYHCG 5000 iu is administered by a qualified healthcare provider.

 

This medication has low acute toxicity, and the typical symptoms of an overdose in humans are not well documented.

 

Prolonged treatment with this medication may lead to various reactions at the injection site, including pain, bruising, redness, itching, and swelling. Some patients treated with ZYHCG 5000 iu have experienced allergic reactions manifesting as rash, discomfort, or swelling at the injection site. Rare side effects of ZYHCG 5000 iu may include fever or rash.

 

Female patients treated with this medication may experience ovarian hyperstimulation syndrome. In male patients receiving ZYHCG 5000 iu, sodium and water retention can occur, particularly following high doses, likely due to excessive androgen production. In some cases, this treatment may lead to gynaecomastia.